express scripts glp 1 coverage Coverage, FDA Label Update Boost Rybelsus NEW: Tricare For Life &
Description
Key qualifiers: "many members" (not all), "up to 25%" (a ceiling, not an average), "over time" (not a specific timeframe)
Ozempic is approved for type 2 diabetes, not weight loss
GLP-1 agonists were originally approved to treat Type 2 Diabetes (T2D) but their most recent incarnations, which consist of both next generation GLP-1s and combinations (Ozempic, Mounjaro, Wegovy, Zepbound), have moved beyond the realm of T2D into the treatment of obesity
Some physicians use lower-dose protocols when the goal is metabolic and inflammatory support rather than maximum weight loss
